Bilton, Edward J. http://orcid.org/0000-0003-4293-1981
Sinclair, Alexandra J. http://orcid.org/0000-0003-2777-5132
Mollan, Susan P. http://orcid.org/0000-0002-6314-4437
Funding for this research was provided by:
Sir Jules Thorn Charitable Trust
Article History
Received: 23 December 2022
Revised: 16 January 2023
Accepted: 15 February 2023
First Online: 24 February 2023
Competing interests
: EJB has no conflicts of interests to declare. AJS reports honoria for speaker events from Teva. Consulting fees from Invex therapeutics; salary and stockholding with Invex therapeutics. SPM reports consultancy fees (Invex Therapeutics); advisory board fees (Invex therapeutics; Gensight) and speaker fees (Heidelberg engineering; Chugai-Roche Ltd; Allergan; Santen; Chiesi; and Santhera).